AI-generated summary
This review examines photobiomodulation, a light therapy using red and near-infrared wavelengths, as a way to shift macrophages toward an anti-inflammatory phenotype in ENT conditions such as chronic rhinosinusitis and otitis media. The authors draw mainly on preclinical studies and report that PBM enhances tissue repair and reduces inflammatory markers. The abstract does not report human clinical outcomes, so these findings should be read as early and largely laboratory-based.
- Who or what was studied
- Preclinical models and ENT inflammatory conditions (chronic rhinosinusitis, otitis media); the number of included studies is not stated.
- Limits stated in the abstract
- The abstract is a narrative review that does not state how many studies were included or report human clinical outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on e-ceo.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Inflammation, Reactive oxygen species, Adenosine triphosphate, Near-infrared, Wound healing, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.